Pharmacokinetics in special populations
- PMID: 19601721
- DOI: 10.1080/10837450902891527
Pharmacokinetics in special populations
Abstract
Pharmacokinetics are typically dependent on a variety of physiological variables (e.g., age, ethnicity, or pregnancy) or pathological conditions (e.g., renal and hepatic insufficiency, cardiac dysfunction, obesity, etc.). The influence of some of these conditions has not always been thoroughly assessed in the clinical studies of antiallergic drugs. However, the knowledge of the physiological grounds of the pharmacokinetics can provide some insight for predicting the potential alterations and guiding the initial prescription strategies. It is important to recognize that both pharmacokinetic and pharmacodynamic differences between populations should be considered. The available information on drugs used for the therapy of allergic diseases is reviewed in this chapter.
Similar articles
-
Population pharmacokinetic and pharmacodynamic analysis in allergic diseases.Drug Metab Rev. 2009;41(3):475-85. doi: 10.1080/10837450902891543. Drug Metab Rev. 2009. PMID: 19601723
-
Drug metabolism and pharmacokinetics.Drug Metab Rev. 2009;41(3):344-90. doi: 10.1080/10837450902891295. Drug Metab Rev. 2009. PMID: 19601718 Review.
-
From pharmacokinetics to therapeutics.Drug Metab Rev. 2009;41(3):455-74. doi: 10.1080/10837450902891535. Drug Metab Rev. 2009. PMID: 19601722 Review.
-
Therapeutic management of allergic diseases.Drug Metab Rev. 2009;41(3):301-43. doi: 10.1080/10837450902891204. Drug Metab Rev. 2009. PMID: 19601717 Review.
-
Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.J Clin Pharmacol. 2009 Apr;49(4):465-76. doi: 10.1177/0091270008330162. J Clin Pharmacol. 2009. PMID: 19318696 Clinical Trial.
Cited by
-
The reference range of lamotrigine in the treatment of epilepsy in children: a systematic review.Eur J Clin Pharmacol. 2024 Jan;80(1):1-10. doi: 10.1007/s00228-023-03562-9. Epub 2023 Oct 31. Eur J Clin Pharmacol. 2024. PMID: 37906300 Free PMC article.
-
Obesity and COVID-19: A jigsaw puzzle with still missing pieces.Clin Obes. 2021 Feb;11(1):e12420. doi: 10.1111/cob.12420. Epub 2020 Oct 18. Clin Obes. 2021. PMID: 33073512 Free PMC article. Review.
-
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.J Pers Med. 2022 Mar 24;12(4):526. doi: 10.3390/jpm12040526. J Pers Med. 2022. PMID: 35455642 Free PMC article.
-
Anthrax edema toxin impairs clearance in mice.Infect Immun. 2012 Feb;80(2):529-38. doi: 10.1128/IAI.05947-11. Epub 2011 Nov 21. Infect Immun. 2012. PMID: 22104108 Free PMC article.
-
Innovative clinical trial design for pediatric therapeutics.Expert Rev Clin Pharmacol. 2011 Sep;4(5):643-52. doi: 10.1586/ecp.11.43. Expert Rev Clin Pharmacol. 2011. PMID: 21980319 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical